Jenny Kobin | executive |
George Lasezkay | executive |
Charlie Deignan | executive |
Serge Belanger | analyst |
Annabel Samimy | analyst |
Andreas Argyrides | analyst |
Yi Chen | analyst |
Good day and thank you for standing by. Welcome to the Clearside Biomedical Quarter 2023 Financial Results and Corporate Update Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker today, Jenny Kobin, Clearside Investor Relations.
Good morning, everyone, and thank you for joining us on the call today.
Before we begin, I would like to remind you that, during today's call, we will be making certain forward-looking statements.